Diana G. Wang

Also affiliated with NewYork–Presbyterian Hospital, Cornell University, New York Hospital Queens, Presbyterian Hospital, Faculty of 1000 (United States), Weill Cornell Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer”.

Dermatologic adverse events related to the PI3Kα inhibitor alpelisib (BYL719) in patients with breast cancer

Breast Cancer Research and Treatment(2020)10.1007/s10549-020-05726-y

N/A

0.550DataRank · unranked

38 citations

Dulce M. Barrios, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

Prevalence and characterization of dermatologic adverse events related to alpelisib (BYL719) in breast cancer patients.

Journal of Clinical Oncology(2020)10.1200/jco.2020.38.15_suppl.1063

N/A

0.241DataRank · unranked

4 citations

Diana G. Wang, Victoria Blinder, Jacqueline Bromberg, Pamela Drullinsky, Samuel A. Funt +10 more

Targeting the PI5P4K Lipid Kinase Family in Cancer Using Covalent Inhibitors

Cell chemical biology(2020)10.1016/j.chembiol.2020.02.003

N/A

0DataRank · unranked

56 citations

Hyeseok Shim, Tinghu Zhang, Fleur M. Ferguson, Mark R. Lundquist, Christopher M. Browne +16 more